|
⚲
|
| Keyboard |
| Tahl Cindy
✚
|
|
|---|---|
| CIK # | 0001655472 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001655472] | |
| 4 | [0001655472] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Tahl Cindy | |
| Fate Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Fate Therapeutics Inc FATE
Stock Option (Right to Buy) · derivative
|
2026-01-15 | Grant | 400,000 | $0.00 | |
|
Fate Therapeutics Inc FATE
Common Stock
|
2026-01-15 | Grant | 100,000 | $0.00 | |
|
Fate Therapeutics Inc FATE
Common Stock
|
2026-01-09 | Sell | 10,589 | $1.06 | 11,224 |
|
Fate Therapeutics Inc FATE
Common Stock
|
2025-08-04 | Sell | 9,037 | $1.06 | 9,579 |
|
Fate Therapeutics Inc FATE
Stock Option (Right to Buy) · derivative
|
2025-01-15 | Grant | 275,000 | $0.00 | |
|
Fate Therapeutics Inc FATE
Common Stock
|
2025-01-15 | Grant | 70,000 | $0.00 | |
|
Fate Therapeutics Inc FATE
Common Stock
|
2025-01-10 | Sell | 5,654 | $1.55 | 8,764 |
|
Fate Therapeutics Inc FATE
Common Stock
|
2024-07-29 | Grant | 200,000 | $0.00 | |
|
Fate Therapeutics Inc FATE
Stock Option (Right to Buy) · derivative
|
2024-02-01 | Grant | 425,000 | $0.00 | |
|
Fate Therapeutics Inc FATE
Common Stock
|
2024-01-09 | Sell | 10,874 | $4.37 | 47,519 |
|
Fate Therapeutics Inc FATE
Common Stock
|
2023-11-09 | Sell | 24,363 | $2.40 | 58,471 |
|
Fate Therapeutics Inc FATE
Stock Option (Right to Buy) · derivative
|
2023-02-06 | Grant | 425,000 | $0.00 | |
|
Fate Therapeutics Inc FATE
Common Stock
|
2023-01-10 | Sell | 11,553 | $5.24 | 60,538 |
|
Fate Therapeutics Inc FATE
Stock Option (Right to Buy) · derivative
|
2022-06-01 | Option exercise | 25,000 | $0.00 | |
|
Fate Therapeutics Inc FATE
Common Stock
|
2022-06-01 | Option exercise | 25,000 | $6.55 | 163,750 |
|
Fate Therapeutics Inc FATE
Common Stock
|
2022-06-01 | Sell | 25,000 | $22.96 | 574,000 |
|
Fate Therapeutics Inc FATE
Common Stock
|
2022-04-01 | Option exercise | 5,567 | $6.55 | 36,464 |
|
Fate Therapeutics Inc FATE
Stock Option (Right to Buy) · derivative
|
2022-04-01 | Option exercise | 19,433 | $0.00 | |
|
Fate Therapeutics Inc FATE
Stock Option (Right to Buy) · derivative
|
2022-04-01 | Option exercise | 5,567 | $0.00 | |
|
Fate Therapeutics Inc FATE
Common Stock
|
2022-04-01 | Sell | 25,000 | $38.85 | 971,250 |
| showing 20 of 131 most recent transactions | |||||